FDA approves device to treat heart failure patients

IANS  |  Washington 

The US has given approval for a new device that would help treat patients with life-threatening heart failure, and address an unmet need in patients who fail to get adequate benefits from standard treatments and have no alternative treatment options.

The Optimizer Smart system is comprised of several components, including an implantable pulse generator, battery charger, and software. The pulse generator is implanted under the skin in the upper left or right area of the chest and connected to three leads that are implanted in the heart.

After the device is implanted, a tests and programmes the device, which delivers electrical impulses to the heart during regular heartbeats to help improve the heart's squeezing capability.

The device would be beneficial for patients not suited to treatment with other devices such as cardiac resynchronisation therapy to restore a normal timing pattern of the heartbeat, the US FDA noted in a statement.

"Patients with moderate-to-severe chronic have limited treatment options. And for those who are unable to be treated due to underlying conditions or who have not responded to available treatments, their quality of life may be impacted, with limits on the types of physical activities they can do," said Bram Zuckerman, at for Devices and Radiological

"The FDA recognised the unmet need for these patients and worked with the manufacturer...to efficiently bring this product to market, while ensuring it meets our regulatory requirements for safety and effectiveness," Zuckerman added.

For the study, the US FDA evaluated data from two clinical trials with a total of 389 patients with moderate-to-severe

All patients received optimal medical therapy and 191 patients also received an Optimizer Smart system implant.

The Optimizer Smart system improves quality of life and functional status of patients.

The body has granted approval of the Optimizer Smart system to US-based Impulse Dynamics.

--IANS

rt/oeb/bc

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, March 22 2019. 19:26 IST